AL-Eitan, L. N., Al-Dalalah, I. M., & Aljamal, H. A. (2019). Effects of GRM4, SCN2A and SCN3B polymorphisms on antiepileptic drugs responsiveness and epilepsy susceptibility. Saudi Pharm J.
Citação norma ChicagoAL-Eitan, Laith N., Islam M. Al-Dalalah, and Hanan A. Aljamal. "Effects of GRM4, SCN2A and SCN3B Polymorphisms On Antiepileptic Drugs Responsiveness and Epilepsy Susceptibility." Saudi Pharm J 2019.
ציטוט MLAAL-Eitan, Laith N., Islam M. Al-Dalalah, and Hanan A. Aljamal. "Effects of GRM4, SCN2A and SCN3B Polymorphisms On Antiepileptic Drugs Responsiveness and Epilepsy Susceptibility." Saudi Pharm J 2019.
אזהרה: ציטוטים אלה לעיתים לא מדויקים ב 100%.